Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05291884 · ClinicalTrials.gov registry record · NA

Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

A NA study of Heart Failure and Acute Decompensated Heart Failure, sponsored by Abiomed.

Active
Registry status
NA
Development phase
10
Enrollment target
6
Study locations

NCT05291884 is a NA study of Heart Failure and Acute Decompensated Heart Failure that is active but no longer recruiting, run by Abiomed. The registered enrollment target is 10 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05291884, a NA study of Heart Failure and Acute Decompensated Heart Failure, is active but no longer recruiting, sponsored by Abiomed.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
6
Study locations

Study Summary

This is a prospective, multi-center, single-arm, early feasibility study that aims to evaluate the safety of the Impella BTR™ in adult patients requiring left-ventricular hemodynamic support, and to evaluate the effectiveness of the Impella BTR™ in supporting patients to recovery or their next therapy.

Conditions Studied

Heart Failure Acute Decompensated Heart Failure

Interventions

  • DEVICE Impella BTR

Study Locations (6)

Massachusetts

  • Tufts Medical Center - Boston
  • Massachusetts General Hospital - Boston

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Northwestern University - Evanston

New Jersey

  • Hackensack University Medical Center - Hackensack

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-04-20
Est. Completion 2028-03
Phase NA

Sponsor

Abiomed

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05291884

The ClinicalTrials.gov registry entry for NCT05291884 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Impella BTR is the first listed.

NCT05291884 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT05291884 about?

NCT05291884 is a clinical study titled "Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study". This is a prospective, multi-center, single-arm, early feasibility study that aims to evaluate the safety of the Impella BTR™ in adult patients requiring left-ventricular hemodynamic support, and to evaluate the effectiveness of the Impella BTR™ in supporting patients to recovery or their next thera...

What is the current status of trial NCT05291884?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-04-20. Estimated completion is 2028-03.

What conditions does trial NCT05291884 study?

This clinical trial studies the following conditions: Heart Failure, Acute Decompensated Heart Failure.

What interventions are being tested in trial NCT05291884?

The interventions under investigation include: Impella BTR (DEVICE).

Who is sponsoring clinical trial NCT05291884?

This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05291884 being conducted?

This trial has 6 study locations across Georgia, Illinois, Massachusetts, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Acute Decompensated Heart Failure

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.